Ignite Creation Date:
2025-12-24 @ 2:02 PM
Ignite Modification Date:
2026-02-27 @ 10:38 AM
Study NCT ID:
NCT02194595
Status:
COMPLETED
Last Update Posted:
2022-04-11
First Post:
2014-07-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
Sponsor:
Mount Sinai Hospital, Canada
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
14-0128-A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None